loader image
Saturday, December 20, 2025
63.8 F
McAllen
- Advertisement -

Community participation needed for “Bras for a Cause”

Translate to Spanish or other 102 languages!

Photo Used for Illustration Purposes. Photo by drazenphoto
- Advertisement -

Every October, DHR Health employees tap into their creativity to participate in the hospital’s annual “Bras for a Cause” fundraiser. This event supports underserved cancer patients throughout the Rio Grande Valley by providing vital resources such as transportation assistance, financial aid, and oncology wigs through the Renaissance Cancer Foundation.

This year, nearly 30 decorated bras were submitted by employees from various departments, showcasing their enthusiasm for raising awareness about breast cancer screenings and mammograms.

“We hold this contest every year as a fun and engaging way for our employees to help promote breast cancer awareness,” said Evelyn Saenz, Executive Director of the Renaissance Cancer Foundation. “We’re always so impressed by the many creative entries we receive.”

- Advertisement -

Community members are encouraged to visit www.dhrhealth.com/brasforacause to view photos of the bra entries and cast their votes by making donations. The bras with the highest donation totals will be declared winners of the fundraiser. Voting is open to the community until October 20, 2024.

All donations to the Renaissance Cancer Foundation are tax-deductible and directly support local cancer patients facing financial challenges during their treatment. For more information about the Renaissance Cancer Foundation or how to get involved, please contact Executive Director Evelyn Saenz at ev.saenz@dhr-rgv.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×